{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:41:45Z","timestamp":1787794905433,"version":"build-2784847793"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jconrel.2015.12.043","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T16:47:05Z","timestamp":1451321225000},"page":"235-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Development of controlled release systems over the past 50 years in the area of contraception"],"prefix":"10.1016","volume":"240","author":[{"given":"David R.","family":"Friend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.12.043_bb0005","first-page":"790154","article-title":"Developing multipurpose reproductive health technologies: an integrated strategy","volume":"2013","author":"Harrison","year":"2013","journal-title":"AIDS Res. Treat."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0010","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s11095-015-1686-2","article-title":"Long-acting injectable hormonal dosage forms for contraception","volume":"32","author":"Wu","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0015","series-title":"Series on Ferility Regulation","first-page":"656","article-title":"Long-acting Contraceptive Delivery Systems","author":"Zatuchni","year":"1984"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2004.01.011","article-title":"Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera\u00ae","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0010-7824(84)90086-6","article-title":"Pharmacokinetics, pharmacodynamic and endometrial effects of a single dose of 200mg norethisterone enanthate","volume":"30","author":"Zal\u00e1nyi","year":"1984","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0010-7824(87)90093-X","article-title":"A multicentred pharmacokinetic. Pharmacodynamic study of once-a-month injec contraceptives I. Different doses of HRP112 and of depoprovera","volume":"36","author":"Garza-Flores","year":"1987","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0010-7824(89)90126-1","article-title":"A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection","volume":"40","author":"World Health","year":"1989","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01849793","article-title":"Long-acting injectable microsphere formulation for the parenteral administration of levonorgestrel","volume":"1","author":"Beck","year":"1985","journal-title":"Adv. Contracept."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-3659(01)00289-9","article-title":"Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions","volume":"73","author":"Berkland","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(02)00136-0","article-title":"Precise control of PLG microsphere size provides enhanced control of drug release rate","volume":"82","author":"Berkland","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2004.10.015","article-title":"Microencapsulation by solvent extraction\/evaporation: reviewing the state of the art of microsphere preparation process technology","volume":"102","author":"Freitas","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0065","doi-asserted-by":"crossref","first-page":"14479","DOI":"10.1021\/la1023136","article-title":"Producing monodisperse drug-loaded polymer microspheres via cross-flow membrane emulsification: the effects of polymers and surfactants","volume":"26","author":"Meyer","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jcis.2010.08.042","article-title":"Facile preparation of fluorescence-encoded microspheres based on microfluidic system","volume":"352","author":"Zhao","year":"2010","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/BF02830623","article-title":"Preparation of gelatin microbeads with a narrow size distribution using microchannel emulsification","volume":"3","author":"Iwamoto","year":"2002","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0010-7824(01)00293-1","article-title":"Progestin implants for female contraception","volume":"65","author":"Croxatto","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0010-7824(98)00110-3","article-title":"Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon","volume":"58","author":"Wenzl","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0090","doi-asserted-by":"crossref","first-page":"91S","DOI":"10.1016\/S0010-7824(98)00118-8","article-title":"The pharmacodynamics and efficacy of Implanon. An overview of the data","volume":"58","author":"Croxatto","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0095","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/zoo.20354","article-title":"The use of long acting subcutaneous levonorgestrel (LNG) gel depot as an effective contraceptive option for cotton-top tamarins (Saguinus oedipus)","volume":"30","author":"Wheaton","year":"2011","journal-title":"Zoo Biol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1586\/17434440.5.5.639","article-title":"Contraceptive devices: intravaginal and intrauterine delivery systems","volume":"5","author":"Benagiano","year":"2008","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/jrf.0.0100115","article-title":"Intra-uterine contraceptive devices","volume":"10","author":"Guttmacher","year":"1965","journal-title":"J. Reprod. Fertil."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0110","first-page":"529","article-title":"Suppression of fertility by intrauterine copper and zinc in rabbits. A new approach to intrauterine contraception","volume":"105","author":"Zipper","year":"1969","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2307\/3030213","article-title":"The checkered history and bright future of intrauterine contraception in the United States","volume":"34","author":"Hubacher","year":"2002","journal-title":"Perspect. Sex. Reprod. Health"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.contraception.2010.09.004","article-title":"Renewed interest in intrauterine contraception in the United States: evidence and explanation","volume":"83","author":"Hubacher","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.contraception.2011.06.007","article-title":"Revival of the intrauterine device: increased insertions among US women with employer-sponsored insurance, 2002\u20132008","volume":"85","author":"Xu","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0010-7824(78)80009-2","article-title":"Determination of plasma concentrations of d-norgestrel during a one year follow-up in women with a d-norgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1978","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0135","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.addr.2009.04.022","article-title":"Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception","volume":"61","author":"Rose","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0140","series-title":"Fourth Conference on IUDs","first-page":"319","article-title":"The Progestasert intrauterine progesterone contraception system. A new look at IUDs-advancing contraceptive choices","author":"Soderstrom","year":"1992"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0145","first-page":"963","article-title":"Intrauterine release of levonorgestrel\u2014a new way of adding progestogen in hormone replacement therapy","volume":"79","author":"Andersson","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0010-7824(80)90127-4","article-title":"Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device","volume":"21","author":"Nilsson","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.contraception.2012.12.013","article-title":"New developments in contraception for US women","volume":"87","author":"Dorflinger","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0170","first-page":"62","article-title":"State of the art in intravaginal ring technology for topical prophylaxis of HIV infection","volume":"14","author":"Kiser","year":"2012","journal-title":"AIDS Rev."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0010-7824(75)90085-2","article-title":"Intravaginal rings for contraceptive use: an editorial comment","volume":"12","author":"Mishell","year":"1975","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0180","unstructured":"G. Duncan, Medicated devices and methods, US Patent 3,545,439, (1970)."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9378(16)33897-2","article-title":"Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate","volume":"107","author":"Mishell","year":"1970","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0015-0282(16)37333-2","article-title":"Contraceptive effect of varying dosages of progestogen in silastic vaginal rings","volume":"21","author":"Mishell","year":"1970","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0195","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1742-1241.2003.tb10514.x","article-title":"Steroidal contraceptive vaginal rings","volume":"57","author":"Sarkar","year":"2003","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9378(73)90735-7","article-title":"Basic studies for prolonged progestogen administration by vaginal devices","volume":"117","author":"Henzl","year":"1973","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0010-7824(85)80005-6","article-title":"Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring","volume":"32","author":"Diaz","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0010-7824(92)90056-Y","article-title":"Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women","volume":"45","author":"Landgren","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0010-7824(95)00042-9","article-title":"The effect of small doses of progesterone released from two types of vaginal rings on ovarian activity and bleeding patterns during the first postpartum year","volume":"51","author":"Landgren","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(97)00008-5","article-title":"Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(99)00057-8","article-title":"Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women","volume":"60","author":"Massai","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0230","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.contraception.2005.05.004","article-title":"Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial","volume":"72","author":"Massai","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0235","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0039-128X(00)00125-2","article-title":"Vaginal rings for contraception in lactating women","volume":"65","author":"Massai","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.01.021","article-title":"Drug delivery systems for hormone therapy","volume":"112","author":"Yoo","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/gye.17.3.247.254","article-title":"Estradiol\/progesterone-releasing vaginal rings for hormone replacement therapy in postmenopausal women","volume":"17","author":"Hamada","year":"2003","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0250","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/07853899309164167","article-title":"Vaginal contraceptive rings","volume":"25","author":"Mishell","year":"1993","journal-title":"Ann. Med."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0255","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0010-7824(82)90132-9","article-title":"Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate","volume":"26","author":"Landgren","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(90)90143-J","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-acting Systemic Agents for Fertility Regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0010-7824(90)90142-I","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task Force on Long-acting Systemic Agents for Fertility Regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0010-7824(90)90141-H","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-acting Systemic Agents for Fertility Regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0010-7824(90)90144-K","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. IV. Bleeding patterns. World Health Organization. Task Force on Long-acting Systemic Agents for Fertility Regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0280","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1006748626008","article-title":"Initial UK experience of the levonorgestrel-releasing contraceptive intravaginal ring","volume":"15","author":"Sahota","year":"1999","journal-title":"Adv. Contracept."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0285","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0010-7824(94)90089-2","article-title":"Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27micrograms\/24hours: a pilot study","volume":"49","author":"Landgren","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0010-7824(94)90083-3","article-title":"Studies on a vaginal ring releasing levonorgestrel at an initial rate of 27micrograms\/24h when used alone or in combination with transdermal systems releasing estradiol","volume":"50","author":"Landgren","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0295","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0010-7824(85)80004-4","article-title":"A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel","volume":"32","author":"Landgren","year":"1985","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0300","first-page":"461","volume":"11","year":"1979","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0305","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v17.i5.30","article-title":"Drug delivery by the intravaginal route","volume":"17","author":"Woolfson","year":"2000","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0310","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/IJWH.S36282","article-title":"Vaginal rings for delivery of HIV microbicides","volume":"4","author":"Malcolm","year":"2012","journal-title":"Int. J. Women's Health"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2015.12.043_bb0315","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.antiviral.2010.09.003","article-title":"Advances in microbicide vaginal rings","volume":"88","author":"Malcolm","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0320","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jps.2600630311","article-title":"Controlled drug release from polymeric devices. I. Technique for rapid in vitro release studies","volume":"63","author":"Chien","year":"1974","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0325","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","article-title":"Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices","volume":"52","author":"Higuchi","year":"1963","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0330","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0168-3659(03)00178-0","article-title":"Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings","volume":"90","author":"Malcolm","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0335","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2010.10.018","article-title":"Mathematical modeling of drug delivery from torus-shaped single-layer devices","volume":"149","author":"Helbling","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0340","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13346-011-0024-4","article-title":"Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections","volume":"1","author":"Friend","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0345","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-5173(01)00900-0","article-title":"In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring","volume":"232","author":"van Laarhoven","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0350","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0355","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2004.08.010","article-title":"Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial","volume":"71","author":"Sivin","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0360","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.contraception.2005.06.071","article-title":"Feasibility study of Nestorone\u00ae\u2013ethinylestradiol vaginal contraceptive ring for emergency contraception","volume":"73","author":"Croxatto","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0365","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/humrep\/deq157","article-title":"Immediate pre-ovulatory administration of 30mg ulipristal acetate significantly delays follicular rupture","volume":"25","author":"Brache","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0370","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/me.2006-0093","article-title":"A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice","volume":"20","author":"Palanisamy","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0375","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2005-864035","article-title":"Progesterone receptor antagonists and the endometrial antiproliferative effect","volume":"23","author":"Brenner","year":"2005","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0380","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0039-128X(00)00190-2","article-title":"Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium","volume":"65","author":"Chwalisz","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0385","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0390","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2011.10.003","article-title":"Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women","volume":"85","author":"Brache","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0395","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.contraception.2014.08.006","article-title":"A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception","volume":"90","author":"Huang","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0405","first-page":"69","article-title":"The transdermal contraceptive patch: a new approach to hormonal contraception","volume":"47","author":"Burkman","year":"2002","journal-title":"Int. J. Fertil. Womens Med."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0410","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra\u00ae) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0415","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00024677-200302030-00005","article-title":"Transdermal ethinylestradiol\/norelgestromin: a review of its use in hormonal contraception","volume":"2","author":"Goa","year":"2003","journal-title":"Treat. Endocrinol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0420","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2015.12.043_bb0425","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.contraception.2011.10.006","article-title":"Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial","volume":"85","author":"Archer","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0430","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u201310","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0435","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0440","series-title":"Assessing the Risk of Venous Thromboembolic Events in Women Taking Progestin-only Contraception: A Meta-Analysis","author":"Mantha","year":"2012"},{"key":"10.1016\/j.jconrel.2015.12.043_bb0445","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.contraception.2012.08.039","article-title":"Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems","volume":"87","author":"Fraser","year":"2013","journal-title":"Contraception"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915302935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915302935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T12:02:14Z","timestamp":1718280134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915302935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":88,"alternative-id":["S0168365915302935"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of controlled release systems over the past 50years in the area of contraception","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}